Japanese spotted fever
Synopsis

Patients typically present with the triad of fever (100%), a diffuse rash (100%), and an eschar (71%–94%). Other symptoms include myalgias, headache (80%), meningoencephalitis, and, in severe cases, multiorgan failure. Only around a third of patients recall a tick bite. Mortality rate overall is about 2%, but those who present late in illness (6 or more days) have an increased rate for complications including multiorgan failure, disseminated intravascular coagulopathy, and death. Laboratory findings associated with increased severity include elevated WBC, elevated creatine kinase, low platelets, elevated fibrin degradation products (FDP), and elevated C-reactive protein (CRP).
Risk factors for exposure are living in or visiting an endemic area, contact with vegetation including both crops and forested areas (early cases were associated with bamboo shoots), and older age (60-70 years on average).
A seasonal variation in incidence has been noted with most cases presenting during the warmer months of April through November. The presumed incubation period is 7 days, like other rickettsioses; however, it has not been well-defined.
Patients who are older and/or have diabetes mellitus may be at increased risk for severe infections.
Codes
A77.8 – Other spotted fevers
SNOMEDCT:
186771002 – Spotted fever group rickettsial disease
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Updated:11/21/2022